Patient
P2B-014
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Stanford University (Stanford, CA) (Dr. Nolan)
consented 2012-06-26
Adverse events
2
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 2
Grade 3 abdominal pain with onset in cycle 4 (2012-09-26); assessed as not related to study drug (unlikely); resolved 2012-10-02; action: drug interrupted.
Grade 1 cough with onset in cycle 2 (2012-08-14); assessed as not related to study drug (unlikely); resolved 2012-09-07.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.